CO 062: THE ROLE OF THE BRAZILIAN CENTER FOR VALIDATION OF ALTERNATIVE METHODS (BraCVAM) IN THE PROCESS OF VALIDATION IN BRAZIL

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S38, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 062: THE ROLE OF THE BRAZILIAN CENTER FOR VALIDATION OF ALTERNATIVE METHODS (BraCVAM) IN THE PROCESS OF VALIDATION IN BRAZIL: LOOKING TO THE FUTURE Presgrave O, Moura W, Caldeira C, Delgado I. Instituto Nacional de … Continue reading CO 062: THE ROLE OF THE BRAZILIAN CENTER FOR VALIDATION OF ALTERNATIVE METHODS (BraCVAM) IN THE PROCESS OF VALIDATION IN BRAZIL

J Pharm Pharmacogn Res 2(Suppl. 1): S38, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 062: THE ROLE OF THE BRAZILIAN CENTER FOR VALIDATION OF ALTERNATIVE METHODS (BraCVAM) IN THE PROCESS OF VALIDATION IN BRAZIL: LOOKING TO THE FUTURE

Presgrave O, Moura W, Caldeira C, Delgado I.

Instituto Nacional de Controle de Qualidade em Saúde (INCQS)/Fundação Oswaldo Cruz (FIOCRUZ), Brasil. E-mail: octavio.presgrave@incqs.fiocruz.br
Abstract

Introduction: Brazilian Law 11,794/2008 rules the animal use and created the Council for the Control of Animal Experimentation (CONCEA) which is responsible, among many other activities, for making alternative methods official in Brazil. The Brazilian Center for Validation of Alternative Methods (BraCVAM) was created in order to identify laboratories and the need of validation, as well as organize and make feasible the execution of validation process.

Objectives: Show how BraCVAM expects to work in Brazil and its relation with similar organizations.

Results: BraCVAM will organize studies to be executed by the National Network on Alternative Methods (RENAMA) following OECD Guideline 34 and it will count on two Committees. The first will peer review the results during the validation and the second will evaluate and recommend finished result to CONCEA. RENAMA received a financial support from National Council of Technological and Scientific Development (CNPq) to help starting two lines: 1) introduction of already validated methods and 2) development of a skin model. It will also be used for starting the process of laboratories accreditation in GLP. BraCVAM was already invited for participating as an observer at the International Cooperation on Alternative Test Methods (ICATM) and to join the OECD Guideline Programme.

Conclusions: Creation of BraCVAM and RENAMA will lead Brazil to join countries that search for alternative methods either for experimental and educational purposes. It makes possible to participate on international studies for validation of methods as well as keep mutual evaluation and acceptance with international 3Rs Centers. BraCVAM and RENAMA will contribute to join institutions that work on alternative methods and it will be possible to develop its own validation strategy of new ingredients or products, especially those ones derived from nature. In a similar way, BraCVAM hope to help the development of networks in Latin America and Caribbean.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio